CHARLOTTE C SUN to Cost-Benefit Analysis
This is a "connection" page, showing publications CHARLOTTE C SUN has written about Cost-Benefit Analysis.
Connection Strength
0.143
-
Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer. Gynecol Oncol. 2021 04; 161(1):56-62.
Score: 0.034
-
Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis. Obstet Gynecol. 2018 07; 132(1):52-58.
Score: 0.029
-
Testing women with endometrial cancer to detect Lynch syndrome. J Clin Oncol. 2011 Jun 01; 29(16):2247-52.
Score: 0.017
-
Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients. J Support Oncol. 2010 Nov-Dec; 8(6):242-51.
Score: 0.017
-
Expanding the criteria for BRCA mutation testing in breast cancer survivors. J Clin Oncol. 2010 Sep 20; 28(27):4214-20.
Score: 0.017
-
Preventing future cancers by testing women with ovarian cancer for BRCA mutations. J Clin Oncol. 2010 Feb 01; 28(4):675-82.
Score: 0.016
-
Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome. Cancer. 2008 Jul 15; 113(2):326-35.
Score: 0.014